Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GetRelief Rx vs MyFastRx

GetRelief Rx
Graded #353

Lower grade

vs+8.699999999999996
MyFastRx
Graded #161

Higher grade

The verdict

MyFastRx takes it — 67.6/100 to 58.9/100.

MyFastRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyFastRx +33
43
76
Dose & formulationGetRelief Rx +6
78
72
Clinical oversightGetRelief Rx +4
70
66
Labs & monitoringEven
52
52
FulfillmentMyFastRx +25
58
83
Contract termsGetRelief Rx +6
47
41
GetRelief Rx · left barMyFastRx · right bar

The numbers

MetricGetRelief RxMyFastRx
WeighScore58.9/10067.6/100
GradeCC
Scorecard rank#353#161
Semaglutide$269/mo (9 mg dose, compounded oral)$169/mo
Tirzepatide$179/mo (16 mg dose, compounded oral)$249/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
GetRelief Rx

Graded #353 · C

Strengths

  • Compounded semaglutide and tirzepatide priced publicly — no login required to see costs
  • BBB accredited with an A rating (March 2026)
  • Free online assessment with no upfront consultation fee

Where it loses points

  • Sublingual drops only — no injectable; this delivery method wasn't studied in the STEP/SURMOUNT trials
  • Still sells compounded tirzepatide after the FDA ended compounding enforcement discretion in 2025
  • No LegitScript, PCAB, or NABP pharmacy certifications found
  • Prescriber credentials listed only as 'licensed clinicians' with no detail on degree type
MyFastRx

Graded #161 · C

Strengths

  • Aggressive 12-month bundle pricing — $99/mo semaglutide, $149/mo tirzepatide
  • LegitScript certified
  • All doses priced the same — no cost escalation as you titrate up
  • First-month promo discount lowers the trial barrier

Where it loses points

  • States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
  • Corporate address and medical director not published
  • Pharmacy partner not named — only 'state-licensed pharmacies'
  • Cash-pay only — no insurance billing
  • Bundle savings require a large upfront commitment (12 months billed at once)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard